Atopic dermatitis: A practice parameter update 2012

Journal of Allergy and Clinical Immunology

Volumn 131, Issue 2, 2013, Pages

  Schneider, Lynda ^a   Tilles, Stephen ^b   Lio, Peter ^b   Boguniewicz, Mark ^b   Beck, Lisa ^b   Lebovidge, Jennifer ^b   Novak, Natalija ^b   Bernstein, David ^b   Blessing Moore, Joann ^b   Khan, David ^b   Lang, David ^b   Nicklas, Richard ^b   Oppenheimer, John ^b   Portnoy, Jay ^b   Randolph, Christopher ^b   Schuller, Diane ^b   Spector, Sheldon ^b   Wallace, Dana ^b  

^a Joint Task Force on Practice Parameters   (United States)

^b NONE

Author keywords

allergen immunotherapy; Atopic dermatitis atopic eczema; cyclosporine; diagnosis; genetics; immunomodulating agents; management; pathogenesis; phototherapy; quality of life; sleep; Staphylococcus; therapy; triggers

Indexed keywords

ANTIHISTAMINIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; DIPHENHYDRAMINE; GAMMA INTERFERON; HYDROCORTISONE BUTYRATE; HYDROXYZINE; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMALIZUMAB; PIMECROLIMUS; RITUXIMAB; TACROLIMUS; TAR; VITAMIN D;

ARTICLE; ATOPIC DERMATITIS; CONSULTATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; EMOTIONAL STRESS; HOSPITALIZATION; HUMAN; HYDRATION; IMMUNOPATHOLOGY; IMMUNOTHERAPY; LOW DRUG DOSE; MALASSEZIA; MEDICAL SOCIETY; NONHUMAN; PATIENT EDUCATION; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SINGLE DRUG DOSE; SKIN CARE; STAPHYLOCOCCUS AUREUS; UNSPECIFIED SIDE EFFECT; WITHDRAWAL SYNDROME;

EID: 84873400547     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.12.672     Document Type: Article

References (249)

1. M. Boguniewicz, and D.Y. Leung Atopic dermatitis: a disease of altered skin barrier and immune dysregulation Immunol Rev 242 2011 233 246 (IV)
2. F. Schultz-Larsen, and J. Hanifin Epidemiology of atopic dermatitis Immunol Allergy Clin North Am 22 2002 1 24 (IV)
3. J.M. Hanifin, and M.L. Reed A population-based survey of eczema prevalence in the United States Dermatitis 18 2007 82 91
4. T. Bieber, and D.Y. Leung Atopic dermatitis 2002 Marcel Dekker New York (IV)
5. D.M. Fleischer, S.A. Bock, G.C. Spears, C.G. Wilson, N.K. Miyazawa, and M.C. Gleason Oral food challenges in children with a diagnosis of food allergy J Pediatr 158 2011 578 583.e1 (III)
6. L.F. Eichenfield, J.M. Hanifin, T.A. Luger, S.R. Stevens, and H.B. Pride Consensus conference on pediatric atopic dermatitis J Am Acad Dermatol 49 2003 1088 1095 (IV)
7. J.M. Hanifin, and G. Rajka Diagnostic features of atopic dermatitis Acta Derm Venereol 92 1980 44 47 (IV)
8. H.A. Sampson, and R. Albergo Comparison of results of skin tests, RAST, and double-blind, placebo-controlled food challenges in children with atopic dermatitis J Allergy Clin Immunol 74 1984 26 33 (IIb)
9. J. Ring, A. Alomar, T. Bieber, M. Deleuran, A. Fink-Wagner, and C. Gelmetti Guidelines for treatment of atopic eczema (atopic dermatitis) Part II J Eur Acad Dermatol Venereol 26 2012 1176 1193 (IV)
10. J. Ring, A. Alomar, T. Bieber, M. Deleuran, A. Fink-Wagner, and C. Gelmetti Guidelines for treatment of atopic eczema (atopic dermatitis) part I J Eur Acad Dermatol Venereol 26 2012 1045 1060 (IV)
11. C. Hoare, A. Li Wan Po, and H. Williams Systematic review of treatments for atopic eczema Health Technol Assess 4 2000 1 191 (Ia)
12. M. Boguniewicz, V.C. Fiedler, S. Raimer, I. Lawrence, D. Leung, and J. Hanifin A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children J Allergy Clin Immunol 102 1998 637 644 (Ia)
13. L.F. Eichenfield, A.W. Lucky, M. Boguniewicz, R.G. Langley, R. Cherill, and K. Marshall Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents J Am Acad Dermatol 46 2002 495 504 (Ia)
14. A. Wollenberg, G. Girolomoni, M. Lahfa, T. Ruzicka, E. Healy, and A. Giannetti Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment Allergy 63 2008 742 750 (Ib)
15. U. Darsow, A. Wollenberg, D. Simon, A. Taieb, T. Werfel, and A. Oranje ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis J Eur Acad Dermatol Venereol 24 2010 317 328 (IV)
16. T. Werfel, C. Claes, W. Kulp, W. Greiner, and J.M. von der Schulenburg Therapy of atopic eczema GMS Health Technol Assess 2 2006 Doc19 (Ib)
17. T. Zuberbier, S.U. Chong, K. Grunow, S. Guhl, P. Welker, and M. Grassberger The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils J Allergy Clin Immunol 108 2001 275 280 (LB)
18. A.C. Devillers, and A.P. Oranje Efficacy and safety of 'wet-wrap' dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature Br J Dermatol 154 2006 579 585 (III)
19. J.H. Lee, S.J. Lee, D. Kim, and D. Bang The effect of wet-wrap dressing on epidermal barrier in patients with atopic dermatitis J Eur Acad Dermatol Venereol 21 2007 1360 1368 (IIb)
20. C. Schnopp, C. Holtmann, S. Stock, R. Remling, R. Folster-Holst, and J. Ring Topical steroids under wet-wrap dressings in atopic dermatitis - a vehicle-controlled trial Dermatology 204 2002 56 59 (IIb)
21. J. Krutmann, T.L. Diepgen, T.A. Luger, S. Grabbe, H. Meffert, and N. Sonnichsen High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial J Am Acad Dermatol 38 1998 589 593 (Ib)
22. S. Tintle, A. Shemer, M. Suarez-Farinas, H. Fujita, P. Gilleaudeau, and M. Sullivan-Whalen Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response J Allergy Clin Immunol 128 2011 583 593.e1-4 (IIb)
23. J. Schmitt, N. Schmitt, and M. Meurer Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis J Eur Acad Dermatol Venereol 21 2007 606 619 (IA)
24. I.M. Haeck, M.J. Knol, O. Ten Berge, S.G. van Velsen, M.S. de Bruin-Weller, and C.A. Bruijnzeel-Koomen Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial J Am Acad Dermatol 64 2011 1074 1084 (Ib)
25. S.J. Meggitt, J.C. Gray, and N.J. Reynolds Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial Lancet 367 2006 839 846 (Ib)
26. H. Williams, C. Robertson, A. Stewart, N. Ait-Khaled, G. Anabwani, and R. Anderson Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood J Allergy Clin Immunol 103 1999 125 138 (III)
27. D.Y. Leung, R.A. Nicklas, J.T. Li, I.L. Bernstein, J. Blessing-Moore, and M. Boguniewicz Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters Ann Allergy Asthma Immunol 93 suppl 2 2004 S1 S21 (IV)
28. A.D. Irvine, W.H. McLean, and D.Y. Leung Filaggrin mutations associated with skin and allergic diseases N Engl J Med 365 2011 1315 1327 (IV)
29. M.K. Oyoshi, R. He, L. Kumar, J. Yoon, and R.S. Geha Cellular and molecular mechanisms in atopic dermatitis Adv Immunol 102 2009 135 226 (IV)
30. A. De Benedetto, N.M. Rafaels, L.Y. McGirt, A.I. Ivanov, S.N. Georas, and C. Cheadle Tight junction defects in patients with atopic dermatitis J Allergy Clin Immunol 127 2011 773 786.e1-7 (LB)
31. N. Novak, and D.Y. Leung Advances in atopic dermatitis Curr Opin Immunol 23 2011 778 783 (IV)
32. L.A. Beck, and D.Y. Leung Allergen sensitization through the skin induces systemic allergic responses J Allergy Clin Immunol 106 suppl 2000 S258 S263 (IV)
33. A. Briot, C. Deraison, M. Lacroix, C. Bonnart, A. Robin, and C. Besson Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome J Exp Med 206 2009 1135 1147 (LB)
34. A. Onoue, K. Kabashima, M. Kobayashi, T. Mori, and Y. Tokura Induction of eosinophil- and Th2-attracting epidermal chemokines and cutaneous late-phase reaction in tape-stripped skin Exp Dermatol 18 2009 1036 1043 (LB)
35. J. Strid, R. Callard, and S. Strobel Epicutaneous immunization converts subsequent and established antigen-specific T helper type 1 (Th1) to Th2-type responses Immunology 119 2006 27 35
36. J. Strid, O. Sobolev, B. Zafirova, B. Polic, and A. Hayday The intraepithelial T cell response to NKG2D-ligands links lymphoid stress surveillance to atopy Science 334 2011 1293 1297 (LB)
37. W.E. Paul, and J. Zhu How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol 10 2010 225 235 (LB)
38. T. Hubiche, C. Ged, A. Benard, C. Leaute-Labreze, K. McElreavey, and H. de Verneuil Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort Acta Derm Venereol 87 2007 499 505 (IIa)
39. L.A. Beck, M. Boguniewicz, T. Hata, L.C. Schneider, J. Hanifin, and R. Gallo Phenotype of atopic dermatitis subjects with a history of eczema herpeticum J Allergy Clin Immunol 124 2009 260 269.e1-7 (III)
40. A.B. Simpson, E. Yousef, and J. Hossain Evaluation of the relationship between IgE level and skin superinfection in children with atopic dermatitis Allergy Asthma Proc 31 2010 232 237 (IIb)
41. S. Eyerich, K. Eyerich, D. Pennino, T. Carbone, F. Nasorri, and S. Pallotta Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling J Clin Invest 119 2009 3573 3585 (LB)
42. K.E. Nograles, L.C. Zaba, A. Shemer, J. Fuentes-Duculan, I. Cardinale, and T. Kikuchi IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells J Allergy Clin Immunol 123 2009 1244 1252.e2 (IIb)
43. H. Fujita, K.E. Nograles, T. Kikuchi, J. Gonzalez, J.A. Carucci, and J.G. Krueger Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production Proc Natl Acad Sci U S A 106 2009 21795 21800 (LB)
44. K. Eyerich, D. Pennino, C. Scarponi, S. Foerster, F. Nasorri, and H. Behrendt IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response J Allergy Clin Immunol 123 2009 59 66.e4 (LB)
45. C. Koga, K. Kabashima, N. Shiraishi, M. Kobayashi, and Y. Tokura Possible pathogenic role of Th17 cells for atopic dermatitis J Invest Dermatol 128 2008 2625 2630 (LB)
46. E. Guttman-Yassky, M.A. Lowes, J. Fuentes-Duculan, L.C. Zaba, I. Cardinale, and K.E. Nograles Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis J Immunol 181 2008 7420 7427 (LB)
47. M. Niebuhr, C. Lutat, S. Sigel, and T. Werfel Impaired TLR-2 expression and TLR-2-mediated cytokine secretion in macrophages from patients with atopic dermatitis Allergy 64 2009 1580 1587 (III)
48. K.C. Barnes An update on the genetics of atopic dermatitis: scratching the surface in 2009 J Allergy Clin Immunol 125 2010 16 31.e1-11 (IV)
49. J.D. Bos, E.J. Van Leent, and J.H. Sillevis Smitt The millennium criteria for the diagnosis of atopic dermatitis Exp Dermatol 7 1998 132 138 (IV)
50. E.E. Brenninkmeijer, M.E. Schram, M.M. Leeflang, J.D. Bos, and P.I. Spuls Diagnostic criteria for atopic dermatitis: a systematic review Br J Dermatol 158 2008 754 765 (III)
51. C.N. Palmer, A.D. Irvine, A. Terron-Kwiatkowski, Y. Zhao, H. Liao, and S.P. Lee Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis Nat Genet 38 2006 441 446 (IIa)
52. B. Wuthrich, and P. Schmid-Grendelmeier The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE-associated ("extrinsic") and the nonallergic ("intrinsic") AEDS J Investig Allergol Clin Immunol 13 2003 1 5 (IV)
53. J. Hara, K. Higuchi, R. Okamoto, M. Kawashima, and G. Imokawa High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis J Invest Dermatol 115 2000 406 413 (LB)
54. G. Imokawa Lipid abnormalities in atopic dermatitis J Am Acad Dermatol 45 suppl 2001 S29 S32 (LB)
55. S.L. Chamlin, I.J. Frieden, A. Fowler, M. Williams, J. Kao, and M. Sheu Ceramide-dominant, barrier-repair lipids improve childhood atopic dermatitis Arch Dermatol 137 2001 1110 1112 (IIb)
56. D.W. Miller, S.B. Koch, B.A. Yentzer, A.R. Clark, J.R. O'Neill, and J. Fountain An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial J Drugs Dermatol 10 2011 531 537 (Ib)
57. A.B. Gutman, A.M. Kligman, J. Sciacca, and W.D. James Soak and smear: a standard technique revisited Arch Dermatol 141 2005 1556 1559 (IIb)
58. C.H. Lee, H.Y. Chuang, C.C. Shih, S.B. Jong, C.H. Chang, and H.S. Yu Transepidermal water loss, serum IgE and beta-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis Br J Dermatol 154 2006 1100 1107 (III)
59. C. Chiang, and L.F. Eichenfield Quantitative assessment of combination bathing and moisturizing regimens on skin hydration in atopic dermatitis Pediatr Dermatol 26 2009 273 278 (IIb)
60. R. Grimalt, V. Mengeaud, and F. Cambazard The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study Dermatology 214 2007 61 67 (Ib)
61. P. Msika, C. De Belilovsky, N. Piccardi, N. Chebassier, C. Baudouin, and B. Chadoutaud New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement Pediatr Dermatol 25 2008 606 612 (Ib)
62. M.J. Cork, J. Britton, L. Butler, S. Young, R. Murphy, and S.G. Keohane Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse Br J Dermatol 149 2003 582 589 (III)
63. L. Warino, R. Balkrishnan, and S.R. Feldman Clobetasol propionate for psoriasis: are ointments really more potent? J Drugs Dermatol 5 2006 527 532 (Ib)
64. R.C. Cornell, and R.B. Stoughton Six-month controlled study of effect of desoximetasone and betamethasone 17-valerate on the pituitary-adrenal axis Br J Dermatol 105 1981 91 95 (Ib)
65. K.A. Fritz, and W.L. Weston Topical glucocorticosteroids Ann Allergy 50 1983 68 76 (IV)
66. A. Wolkerstorfer, M.A. Strobos, E.J. Glazenburg, P.G. Mulder, and A.P. Oranje Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitis J Am Acad Dermatol 39 1998 226 231 (II)
67. B.R. Lagos, and H.I. Maibach Frequency of application of topical corticosteroids: an overview Br J Dermatol 139 1998 763 766 (IV)
68. J.B. Van Der Meer, E.J. Glazenburg, P.G. Mulder, H.F. Eggink, and P.J. Coenraads The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic Dermatitis Study Group Br J Dermatol 140 1999 1114 1121
69. J. Berth-Jones, R.J. Damstra, S. Golsch, J.K. Livden, O. Van Hooteghem, and F. Allegra Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study BMJ 326 2003 1367 (Ib)
70. J. Schmitt, L. von Kobyletzki, A. Svensson, and C. Apfelbacher Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials Br J Dermatol 164 2011 415 428 (Ia)
71. A. Wollenberg, S. Sharma, D. von Bubnoff, E. Geiger, J. Haberstok, and T. Bieber Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis J Allergy Clin Immunol 107 2001 519 525 (LB)
72. T. Ruzicka, T. Bieber, E. Schopf, A. Rubins, A. Dobozy, and J.D. Bos A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group N Engl J Med 337 1997 816 821 (Ib)
73. A. Paller, L.F. Eichenfield, D.Y. Leung, D. Stewart, and M. Appell A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients J Am Acad Dermatol 44 suppl 2001 S47 S57 (Ib)
74. J.M. Hanifin, M.R. Ling, R. Langley, D. Breneman, and E. Rafal Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy J Am Acad Dermatol 44 suppl 2001 S28 S38 (Ib)
75. L. Drake, M. Prendergast, R. Maher, D. Breneman, N. Korman, and Y. Satoi The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis J Am Acad Dermatol 44 suppl 2001 S65 S72 (Ia)
76. S. Kang, A.W. Lucky, D. Pariser, I. Lawrence, and J.M. Hanifin Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children J Am Acad Dermatol 44 suppl 2001 S58 S64 (IIb)
77. S. Reitamo, A. Wollenberg, E. Schopf, J.L. Perrot, R. Marks, and T. Ruzicka Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group Arch Dermatol 136 2000 999 1006 (IIb)
78. P.J. Hauk, and D.Y. Leung Tacrolimus (FK506): new treatment approach in superantigen-associated diseases like atopic dermatitis? J Allergy Clin Immunol 107 2001 391 392 (IV)
79. H. Sugiura, M. Uehara, N. Hoshino, and A. Yamaji Long-term efficacy of tacrolimus ointment for recalcitrant facial erythema resistant to topical corticosteroids in adult patients with atopic dermatitis Arch Dermatol 136 2000 1062 1063 (IIb)
80. S. Reitamo, M. Rustin, T. Ruzicka, F. Cambazard, K. Kalimo, and P.S. Friedmann Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis J Allergy Clin Immunol 109 2002 547 555 (Ib)
81. S. Reitamo, E.J. Van Leent, V. Ho, J. Harper, T. Ruzicka, and K. Kalimo Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis J Allergy Clin Immunol 109 2002 539 546 (Ib)
82. S. Reitamo, and R. Allsopp Treatment with twice-weekly tacrolimus ointment in patients with moderate to severe atopic dermatitis: results from two randomized, multicentre, comparative studies J Dermatolog Treat 21 2010 34 44 (Ib)
83. J. Lubbe, C.C. Pournaras, and J.H. Saurat Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment Dermatology 201 2000 249 251 (IV)
84. M. Boguniewicz, N. Nicol, K. Kelsay, and D.Y. Leung A multidisciplinary approach to evaluation and treatment of atopic dermatitis Semin Cutan Med Surg 27 2008 115 127 (IV)
85. M. Kim, M. Jung, S.P. Hong, H. Jeon, M.J. Kim, and M.Y. Cho Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function Exp Dermatol 19 2010 501 510 (IIa)
86. A. Remitz, H. Kyllonen, H. Granlund, and S. Reitamo Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions [letter] J Allergy Clin Immunol 107 2001 196 197 (IV)
87. A. Stuetz, M. Grassberger, and J.G. Meingassner Pimecrolimus (Elidel, SDZ ASM 981) - preclinical pharmacologic profile and skin selectivity Semin Cutan Med Surg 20 2001 233 241 (IV)
88. E.J. Van Leent, M.E. Ebelin, P. Burtin, B. Dorobek, P.I. Spuls, and J.D. Bos Low systemic exposure after repeated topical application of Pimecrolimus (Elidel), SD Z ASM 981) in patients with atopic dermatitis Dermatology 204 2002 63 68 (IIb)
89. C. Queille-Roussel, C. Paul, L. Duteil, M.C. Lefebvre, G. Rapatz, and M. Zagula The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study Br J Dermatol 144 2001 507 513
90. L.F. Eichenfield, V. Ho, J. Matsunaga, P. Leclerc, C. Paul, and J.M. Hanifin Blood concentrations, tolerability and efficacy of pimecrolimus cream 1% in Japanese infants and children with atopic dermatitis J Dermatol 34 2007 231 236 (IIb)
91. A. Kapp, K. Papp, A. Bingham, R. Folster-Holst, J.P. Ortonne, and P.C. Potter Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug J Allergy Clin Immunol 110 2002 277 284 (Ib)
92. R. Kaufmann, R. Folster-Holst, P. Hoger, D. Thaci, H. Loffler, and D. Staab Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants J Allergy Clin Immunol 114 2004 1183 1188 (Ib)
93. K.A. Papp, K. Breuer, M. Meurer, J.P. Ortonne, P.C. Potter, and Y. de Prost Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination J Am Acad Dermatol 52 2005 247 253 (IIb)
94. K.A. Papp, T. Werfel, R. Folster-Holst, J.P. Ortonne, P.C. Potter, and Y. de Prost Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study J Am Acad Dermatol 52 2005 240 246 (Ib)
95. J. Ring, A. Abraham, C. de Cuyper, K. Kim, T. Langeland, and V. Parra Control of atopic eczema with pimecrolimus cream 1% under daily practice conditions: results of a >2000 patient study J Eur Acad Dermatol Venereol 22 2008 195 203
96. C. Paul, M. Cork, A.B. Rossi, K.A. Papp, N. Barbier, and Y. de Prost Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years Pediatrics 117 2006 e118 e128 (IIb)
97. U. Wahn, J.D. Bos, M. Goodfield, R. Caputo, K. Papp, and A. Manjra Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children Pediatrics 110 2002 e2 (Ib)
98. L. Fonacier, E.N. Charlesworth, J.M. Spergel, and D.Y. Leung The black box warning for topical calcineurin inhibitors: looking outside the box Ann Allergy Asthma Immunol 97 2006 117 120
99. F.M. Arellano, C.E. Wentworth, A. Arana, C. Fernandez, and C.F. Paul Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis J Invest Dermatol 127 2007 808 816 (III)
100. J.B. Slutsky, R.A. Clark, A.A. Remedios, and P.A. Klein An evidence-based review of the efficacy of coal tar preparations in the treatment of psoriasis and atopic dermatitis J Drugs Dermatol 9 2010 1258 1264 (Ib)
101. A.M. Niordson, and D. Stahl Treatment of psoriasis with Clinitar Cream. A controlled clinical trial Br J Clin Pract 39 1985 67 68 72. (IIa)
102. J.H. Roelofzen, K.K. Aben, U.T. Oldenhof, P.J. Coenraads, H.A. Alkemade, and P.C. van de Kerkhof No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema J Invest Dermatol 130 2010 953 961 (III)
103. P.A. Klein, and R.A. Clark An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis Arch Dermatol 135 1999 1522 1525
104. J. Munday, R. Bloomfield, M. Goldman, H. Robey, G.J. Kitowska, and Z. Gwiezdziski Chlorpheniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component Dermatology 205 2002 40 45 (Ib)
105. F.E. Simons Prevention of acute urticaria in young children with atopic dermatitis J Allergy Clin Immunol 107 2001 703 706 (Ib)
106. T.L. Diepgen Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months Pediatr Allergy Immunol 13 2002 278 286 (Ib)
107. J. Hrachovec Publication bias with cetirizine in atopic dermatitis: safe but ineffective? J Allergy Clin Immunol 110 2002 818
108. M. La Rosa, C. Ranno, I. Musarra, F. Guglielmo, A. Corrias, and J.A. Bellanti Double-blind study of cetirizine in atopic eczema in children Ann Allergy 73 1994 117 122 (Ib)
109. T. Langeland, H.E. Fagertun, and S. Larsen Therapeutic effect of loratadine on pruritus in patients with atopic dermatitis. A multi-crossover-designed study Allergy 49 1994 22 26 (Ib)
110. M. Hannuksela, K. Kalimo, K. Lammintausta, T. Mattila, K. Turjanmaa, and E. Varjonen Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults Ann Allergy 70 1993 127 133 (Ib)
111. W.B. Shelley, E.D. Shelley, and N.Y. Talanin Self-potentiating allergic contact dermatitis caused by doxepin hydrochloride cream J Am Acad Dermatol 34 1996 143 144 (IV)
112. L.A. Drake, J.D. Fallon, and A. Sober Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group J Am Acad Dermatol 31 1994 613 616 (Ib)
113. R. Sidbury, A.F. Sullivan, R.I. Thadhani, and C.A. Camargo Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study Br J Dermatol 159 2008 245 247 (Ib)
114. M.H. Javanbakht, S.A. Keshavarz, M. Djalali, F. Siassi, M.R. Eshraghian, and A. Firooz Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis J Dermatolog Treat 22 2011 144 150 (Ib)
115. D.G. Peroni, G.L. Piacentini, E. Cametti, I. Chinellato, and A.L. Boner Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children Br J Dermatol 164 2011 1078 1082 (III)
116. P.J. Frosch, and T. Rustemeyer Contact allergy to calcipotriol does exist. Report of an unequivocal case and review of the literature Contact Dermatitis 40 1999 66 71 (III)
117. A. Feily, and M.R. Namazi Vitamin A + D ointment is not an appropriate emollient for atopic dermatitis Dermatitis 21 2010 174 175 (IV)
118. A.J. Birnie, F.J. Bath-Hextall, J.C. Ravenscroft, and H.C. Williams Interventions to reduce Staphylococcus aureus in the management of atopic eczema Cochrane Database Syst Rev 3 2008 CD003871 (Ia)
119. A.C. Krakowski, L.F. Eichenfield, and M.A. Dohil Management of atopic dermatitis in the pediatric population Pediatrics 122 2008 812 824 (IV)
120. J.T. Huang, M. Abrams, B. Tlougan, A. Rademaker, and A.S. Paller Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity Pediatrics 123 2009 e808 e814 (Ib)
121. A. Nassif, S.C. Chan, F.J. Storrs, and J.M. Hanifin Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis Arch Dermatol 130 1994 1402 1407 (IIb)
122. J.A. Boyce, A. Assa'ad, A.W. Burks, S.M. Jones, H.A. Sampson, and R.A. Wood Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report J Allergy Clin Immunol 126 2010 1105 1118 (IV)
123. I.L. Bernstein, J.T. Li, D.I. Bernstein, R. Hamilton, S.L. Spector, and R. Tan Allergy diagnostic testing: an updated practice parameter Ann Allergy Asthma Immunol 100 suppl 3 2008 S1 S148 (IV)
124. K.M. Saarinen, H. Suomalainen, and E. Savilahti Diagnostic value of skin-prick and patch tests and serum eosinophil cationic protein and cow's milk-specific IgE in infants with cow's milk allergy Clin Exp Allergy 31 2001 423 429 (IIb)
125. J.L. Sinagra, V. Bordignon, C. Ferraro, A. Cristaudo, M. Di Rocco, and B. Amorosi Unnecessary milk elimination diets in children with atopic dermatitis Pediatr Dermatol 24 2007 1 6 (III)
126. F. Bath-Hextall, F.M. Delamere, and H.C. Williams Dietary exclusions for improving established atopic eczema in adults and children: systematic review Allergy 64 2009 258 264 (IV)
127. A. Verstege, A. Mehl, C. Rolinck-Werninghaus, U. Staden, M. Nocon, and K. Beyer The predictive value of the skin prick test weal size for the outcome of oral food challenges Clin Exp Allergy 35 2005 1220 1226
128. H.A. Sampson Utility of food-specific IgE concentrations in predicting symptomatic food allergy J Allergy Clin Immunol 107 2001 891 896 (IIb)
129. T. Komata, L. Soderstrom, M.P. Borres, H. Tachimoto, and M. Ebisawa The predictive relationship of food-specific serum IgE concentrations to challenge outcomes for egg and milk varies by patient age J Allergy Clin Immunol 119 2007 1272 1274 (IIb)
130. T.T. Perry, E.C. Matsui, M. Kay Conover-Walker, and R.A. Wood The relationship of allergen-specific IgE levels and oral food challenge outcome J Allergy Clin Immunol 114 2004 144 149 (IIb)
131. S.H. Sicherer, E.H. Morrow, and H.A. Sampson Dose-response in double-blind, placebo-controlled oral food challenges in children with atopic dermatitis J Allergy Clin Immunol 105 2000 582 586 (IIb)
132. T. van der Zee, A. Dubois, M. Kerkhof, S. van der Heide, and B. Vlieg-Boerstra The eliciting dose of peanut in double-blind, placebo-controlled food challenges decreases with increasing age and specific IgE level in children and young adults J Allergy Clin Immunol 128 2011 1031 1036 (IIb)
133. B. Niggemann, S. Reibel, C.C. Roehr, D. Felger, M. Ziegert, and C. Sommerfeld Predictors of positive food challenge outcome in non-IgE-mediated reactions to food in children with atopic dermatitis J Allergy Clin Immunol 108 2001 1053 1058
134. R.A. Tupker, J.G. De Monchy, P.J. Coenraads, A. Homan, and J.B. van der Meer Induction of atopic dermatitis by inhalation of house dust mite J Allergy Clin Immunol 97 1996 1064 1070 (Ib)
135. U. Darsow, J. Laifaoui, K. Kerschenlohr, A. Wollenberg, B. Przybilla, and B. Wuthrich The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study Allergy 59 2004 1318 1325
136. S. Seidenari, F. Giusti, G. Pellacani, and L. Bertoni Frequency and intensity of responses to mite patch tests are lower in nonatopic subjects with respect to patients with atopic dermatitis Allergy 58 2003 426 429
137. C. Gutgesell, S. Heise, S. Seubert, A. Seubert, S. Domhof, and E. Brunner Atopic dermatitis, house-dust mite, and the placebo effect Allergy 56 2001 1226 1227
138. L. Holm, A. Bengtsson, M. van Hage-Hamsten, S. Ohman, and A. Scheynius Effectiveness of occlusive bedding in the treatment of atopic dermatitis - a placebo-controlled trial of 12 months' duration Allergy 56 2001 152 158 (Ib)
139. B.B. Tan, D. Weald, I. Strickland, and P.S. Friedmann Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis Lancet 347 1996 15 18 (Ib)
140. A.J. Oosting, M.S. de Bruin-Weller, I. Terreehorst, Z. Tempels-Pavlica, R.C. Aalberse, and J.G. de Monchy Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study J Allergy Clin Immunol 110 2002 500 506 (Ib)
141. L.G. Arlian, and T.A. Platts-Mills The biology of dust mites and the remediation of mite allergens in allergic disease J Allergy Clin Immunol 107 suppl 2001 S406 S413 (IV)
142. D.Y. Leung, R. Harbeck, P. Bina, R.F. Reiser, E. Yang, and D.A. Norris Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens J Clin Invest 92 1993 1374 1380 (III)
143. I. Nomura, K. Tanaka, H. Tomita, T. Katsunuma, Y. Ohya, and N. Ikeda Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis J Allergy Clin Immunol 104 1999 441 446 (III)
144. R. Bunikowski, M.E. Mielke, H. Skarabis, M. Worm, I. Anagnostopoulos, and G. Kolde Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis J Allergy Clin Immunol 105 2000 814 819 (III)
145. C. Bussmann, T. Bieber, and N. Novak Systemic therapeutic options for severe atopic dermatitis J Dtsch Dermatol Ges 7 2009 205 219 (IV)
146. M. Boguniewicz, H. Sampson, S.B. Leung, R. Harbeck, and D.Y. Leung Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis J Allergy Clin Immunol 108 2001 651 652 (III)
147. K. Chua, F. Laurent, G. Coombs, M.L. Grayson, and B.P. Howden Antimicrobial resistance: not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy Clin Infect Dis 52 2011 99 114 (IV)
148. J. Wohlrab, G. Jost, and D. Abeck Antiseptic efficacy of a low-dosed topical triclosan/chlorhexidine combination therapy in atopic dermatitis Skin Pharmacol Physiol 20 2007 71 76 (IIb)
149. K. Brockow, P. Grabenhorst, D. Abeck, B. Traupe, J. Ring, and U. Hoppe Effect of gentian violet, corticosteroid and tar preparations in Staphylococcus aureus-colonized atopic eczema Dermatology 199 1999 231 236 (IIb)
150. A. Gauger, M. Mempel, A. Schekatz, T. Schafer, J. Ring, and D. Abeck Silver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczema Dermatology 207 2003 15 21 (IIa)
151. G. Ricci, A. Patrizi, B. Bendandi, G. Menna, E. Varotti, and M. Masi Clinical effectiveness of a silk fabric in the treatment of atopic dermatitis Br J Dermatol 150 2004 127 131 (IIa)
152. E.J. Nilsson, C.G. Henning, and J. Magnusson Topical corticosteroids and Staphylococcus aureus in atopic dermatitis J Am Acad Dermatol 27 1992 29 34 (III)
153. S.H. Cho, I. Strickland, M. Boguniewicz, and D.Y. Leung Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin J Allergy Clin Immunol 108 2001 269 274 (III)
154. P.Y. Ong, T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, and T. Ganz Endogenous antimicrobial peptides and skin infections in atopic dermatitis N Engl J Med 347 2002 1151 1160 (IIa)
155. A. Wollenberg, S. Wetzel, W.H. Burgdorf, and J. Haas Viral infections in atopic dermatitis: pathogenic aspects and clinical management J Allergy Clin Immunol 112 2003 667 674 (IV)
156. V.M. Novelli, D.J. Atherton, and W.C. Marshall Eczema herpeticum. Clinical and laboratory features Clin Pediatr (Phila) 27 1988 231 233 (III)
157. K. Bork, and W. Brauninger Increasing incidence of eczema herpeticum: analysis of seventy-five cases J Am Acad Dermatol 19 1988 1024 1029 (III)
158. R.J. Engler, J. Kenner, and D.Y. Leung Smallpox vaccination: Risk considerations for patients with atopic dermatitis J Allergy Clin Immunol 110 2002 357 365 (IV)
159. S. Vora, I. Damon, V. Fulginiti, S.G. Weber, M. Kahana, and S.L. Stein Severe eczema vaccinatum in a household contact of a smallpox vaccinee Clin Infect Dis 46 2008 1555 1561 (III)
160. A. Zargari, H. Eshaghi, O. Back, S. Johansson, and A. Scheynius Serum IgE reactivity to Malassezia furfur extract and recombinant M. furfur allergens in patients with atopic dermatitis Acta Derm Venereol 81 2001 418 422 (III)
161. K. Darabi, S.G. Hostetler, M.A. Bechtel, and M. Zirwas The role of Malassezia in atopic dermatitis affecting the head and neck of adults J Am Acad Dermatol 60 2009 125 136 (IV)
162. P. Schmid-Grendelmeier, S. Fluckiger, R. Disch, A. Trautmann, B. Wuthrich, and K. Blaser IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis J Allergy Clin Immunol 115 2005 1068 1075 (IIb)
163. P. Lintu, J. Savolainen, O. Kortekangas-Savolainen, and K. Kalimo Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts Allergy 56 2001 512 517 (Ib)
164. P. Mayser, J. Kupfer, D. Nemetz, U. Schafer, M. Nilles, and W. Hort Treatment of head and neck dermatitis with ciclopiroxolamine cream - results of a double-blind, placebo-controlled study Skin Pharmacol Physiol 19 2006 153 158 (IIa)
165. S.L. Chamlin, I.J. Frieden, M.L. Williams, and M.M. Chren Effects of atopic dermatitis on young American children and their families Pediatrics 114 2004 607 611 (III)
166. S. Alanne, M. Nermes, R. Soderlund, and K. Laitinen Quality of life in infants with atopic dermatitis and healthy infants: a follow-up from birth to 24 months Acta Paediatr 100 2011 e65 e70 (III)
167. T. Zuberbier, S.J. Orlow, A.S. Paller, A. Taieb, R. Allen, and J.M. Hernanz-Hermosa Patient perspectives on the management of atopic dermatitis J Allergy Clin Immunol 118 2006 226 232 (III)
168. K. Moore, T.J. David, C.S. Murray, F. Child, and P.D. Arkwright Effect of childhood eczema and asthma on parental sleep and well-being: a prospective comparative study Br J Dermatol 154 2006 514 518 (IIb)
169. J.C. Su, A.S. Kemp, G.A. Varigos, and T.M. Nolan Atopic eczema: its impact on the family and financial cost Arch Dis Child 76 1997 159 162 (III)
170. L.R. Daud, M.E. Garralda, and T.J. David Psychosocial adjustment in preschool children with atopic eczema Arch Dis Child 69 1993 670 676 (III)
171. J. Schmitt, C. Apfelbacher, C.M. Chen, M. Romanos, S. Sausenthaler, and S. Koletzko Infant-onset eczema in relation to mental health problems at age 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus) J Allergy Clin Immunol 125 2010 404 410 (III)
172. A. Wittkowski, H.L. Richards, C.E. Griffiths, and C.J. Main The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis J Psychosom Res 57 2004 195 200
173. J. Schmitt, M. Romanos, A. Pfennig, K. Leopold, and M. Meurer Psychiatric comorbidity in adult eczema Br J Dermatol 161 2009 878 883
174. S.L. Chamlin, C.L. Mattson, I.J. Frieden, M.L. Williams, A.J. Mancini, and D. Cella The price of pruritus: sleep disturbance and cosleeping in atopic dermatitis Arch Pediatr Adolesc Med 159 2005 745 750 (III)
175. R.E. Dahl, J. Bernhisel-Broadbent, S. Scanlon-Holdford, H.A. Sampson, and M. Lupo Sleep disturbances in children with atopic dermatitis Arch Pediatr Adolesc Med 149 1995 856 860 (III)
176. M. Romanos, M. Gerlach, A. Warnke, and J. Schmitt Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample J Epidemiol Community Health 64 2010 269 273 (III)
177. H. Reuveni, G. Chapnick, A. Tal, and A. Tarasiuk Sleep fragmentation in children with atopic dermatitis Arch Pediatr Adolesc Med 153 1999 249 253 (III)
178. T. Bieber, K. Vick, R. Folster-Holst, A. Belloni-Fortina, G. Stadtler, and M. Worm Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis Allergy 62 2007 184 189 (Ib)
179. H.L. Leo, B.G. Bender, S.B. Leung, Z.V. Tran, and D.Y. Leung Effect of pimecrolimus cream 1% on skin condition and sleep disturbance in children with atopic dermatitis J Allergy Clin Immunol 114 2004 691 693 (Ib)
180. K. Kelsay Management of sleep disturbance associated with atopic dermatitis J Allergy Clin Immunol 118 2006 198 201 (IV)
181. R. King, and G. Wilson Use of a diary technique to investigate psychosomatic relations in atopic dermatitis J Pyschosom Res 35 1991 697 706 (III)
182. A. Kodama, T. Horikawa, T. Suzuki, W. Ajiki, T. Takashima, and S. Harada Effect of stress on atopic dermatitis: investigation in patients after the great Hanshin earthquake J Allergy Clin Immunol 104 1999 173 176
183. G. Schmid-Ott, B. Jaeger, C. Adamek, H. Koch, F. Lamprecht, and A. Kapp Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis J Allergy Clin Immunol 107 2001 171 177
184. G. Schmid-Ott, B. Jaeger, S. Meyer, E. Stephan, A. Kapp, and T. Werfel Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison with healthy controls J Allergy Clin Immunol 108 2001 455 462
185. A. Buske-Kirschbaum, A. Gierens, H. Hollig, and D.H. Hellhammer Stress-induced immunomodulation is altered in patients with atopic dermatitis J Neuroimmunol 129 2002 161 167
186. Y. Chida, A. Steptoe, N. Hirakawa, N. Sudo, and C. Kubo The effects of psychological intervention on atopic dermatitis. A systematic review and meta-analysis Int Arch Allergy Immunol 144 2007 1 9
187. B.G. Bae, S.H. Oh, C.O. Park, S. Noh, J.Y. Noh, and K.R. Kim Progressive muscle relaxation therapy for atopic dermatitis: objective assessment of efficacy Acta Derm Venereol 92 2012 57 61 (Ib)
188. J. Kupfer, U. Gieler, T.L. Diepgen, M. Fartasch, T. Lob-Corzilius, and J. Ring Structured education program improves the coping with atopic dermatitis in children and their parents-a multicenter, randomized controlled trial J Psychosom Res 68 2010 353 358 (Ib)
189. J.S. Chou, J. LeBovidge, K. Timmons, W. Elverson, J. Morrill, and L.C. Schneider Predictors of clinical success in a multidisciplinary model of atopic dermatitis treatment Allergy Asthma Proc 32 2011 377 383 (III)
190. D. Staab, T.L. Diepgen, M. Fartasch, J. Kupfer, T. Lob-Corzilius, and J. Ring Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial BMJ 332 2006 933 938 (Ib)
191. E.J. Moore, A. Williams, E. Manias, G. Varigos, and S. Donath Eczema workshops reduce severity of childhood atopic eczema Australas J Dermatol 50 2009 100 106 (Ib)
192. M. Grillo, L. Gassner, G. Marshman, S. Dunn, and P. Hudson Pediatric atopic eczema: the impact of an educational intervention Pediatr Dermatol 23 2006 428 436
193. D. Staab, U. von Rueden, R. Kehrt, M. Erhart, K. Wenninger, and P. Kamtsiuris Evaluation of a parental training program for the management of childhood atopic dermatitis Pediatr Allergy Immunol 13 2002 84 90
194. J.F. Rork, W.J. Sheehan, J.M. Gaffin, K.G. Timmons, R. Sidbury, and L.C. Schneider Parental response to written eczema action plans in children with eczema Arch Dermatol 148 2012 391 392 (IIb)
195. A.Y. Pei, H.H. Chan, and K.M. Ho The effectiveness of wet wrap dressings using 0.1% mometasone furoate and 0.005% fluticasone proprionate ointments in the treatment of moderate to severe atopic dermatitis in children Pediatr Dermatol 18 2001 343 348 (Ib)
196. M.S. Salek, A.Y. Finlay, D.K. Luscombe, B.R. Allen, J. Berth-Jones, and R.D. Camp Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial Br J Dermatol 129 1993 422 430 (Ib)
197. J.M. Sowden, J. Berth-Jones, J.S. Ross, R.J. Motley, R. Marks, and A.Y. Finlay Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis Lancet 338 1991 137 140 (Ib)
198. T. van Joost, F. Heule, M. Korstanje, M.J. van den Broek, H.J. Stenveld, and W.A. van Vloten Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study Br J Dermatol 130 1994 634 640 (Ib)
199. J.I. Harper, J. Berth-Jones, R.D. Camp, M.J. Dillon, A.Y. Finlay, and C.A. Holden Cyclosporin for atopic dermatitis in children Dermatology 203 2001 3 6 (IV)
200. A. Benez, and G. Fierlbeck Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil Br J Dermatol 144 2001 638 639 (III)
201. M. Grundmann-Kollmann, M. Podda, F. Ochsendorf, W.H. Boehncke, R. Kaufmann, and T.M. Zollner Mycophenolate mofetil is effective in the treatment of atopic dermatitis Arch Dermatol 137 2001 870 873
202. M. Heller, H.T. Shin, S.J. Orlow, and J.V. Schaffer Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients Br J Dermatol 157 2007 127 132 (III)
203. N. Kuanprasert, O. Herbert, and R.S. Barnetson Clinical improvement and significant reduction of total serum IgE in patients suffering from severe atopic dermatitis treated with oral azathioprine Australas J Dermatol 43 2002 125 127 (III)
204. J. Berth-Jones, A. Takwale, E. Tan, G. Barclay, S. Agarwal, and I. Ahmed Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial Br J Dermatol 147 2002 324 330 (Ib)
205. J.L. Snow, and L.E. Gibson A pharmacogenetic basis for the safe and effective use of azathioprine and other thiopurine drugs in dermatologic patients J Am Acad Dermatol 32 1995 114 116 (Ib)
206. J.L. Snow, and L.E. Gibson The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients Arch Dermatol 131 1995 193 197 (Ib)
207. M.E. Schram, R.J. Borgonjen, C.M. Bik, J.G. van der Schroeff, J.J. van Everdingen, and P.I. Spuls Off-label use of azathioprine in dermatology: a systematic review Arch Dermatol 147 2011 474 488 (Ib)
208. M.E. Schram, E. Roekevisch, M.M. Leeflang, J.D. Bos, J. Schmitt, and P.I. Spuls A randomized trial of methotrexate versus azathioprine for severe atopic eczema J Allergy Clin Immunol 128 2011 353 359 (Ib)
209. M. Boguniewicz, H.S. Jaffe, A. Izu, M.J. Sullivan, D. York, and R.S. Geha Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels Am J Med 88 1990 365 370 (IIb)
210. J.M. Hanifin, L.C. Schneider, D.Y. Leung, C.N. Ellis, H.S. Jaffe, and A.E. Izu Recombinant interferon gamma therapy for atopic dermatitis J Am Acad Dermatol 28 1993 189 197 (Ib)
211. U. Reinhold, S. Kukel, J. Brzoska, and H.W. Kreysel Systemic interferon gamma treatment in severe atopic dermatitis J Am Acad Dermatol 29 1993 58 63 (III)
212. L.C. Schneider, Z. Baz, C. Zarcone, and D. Zurakowski Long-term therapy with recombinant interferon-gamma (rIFN-gamma) for atopic dermatitis Ann Allergy Asthma Immunol 80 1998 263 268 (III)
213. R.J. Heddle, J.F. Soothill, C.J. Bulpitt, and D.J. Atherton Combined oral and nasal beclomethasone diproprionate in children with atopic eczema: a randomised controlled trial BMJ 289 1984 651 654 (Ib)
214. M. La Rosa, I. Musarra, C. Ranno, N. Maiello, L. Negri, and M.M. Del Giudice A randomized, double-blind, placebo-controlled crossover trial of systemic flunisolide in the treatment of children with severe atopic dermatitis Curr Ther Res Clin Exp 56 1995 720 726 (Ib)
215. E. Galli, L. Chini, V. Moschese, F. Paone, A. Menichelli, and G. Fraioli Methylprednisolone bolus: a novel therapy for severe atopic dermatitis Acta Paediatr 83 1994 315 317 (III)
216. C.A. Akdis, M. Akdis, T. Bieber, C. Bindslev-Jensen, M. Boguniewicz, and P. Eigenmann Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report J Allergy Clin Immunol 118 2006 152 169 (IV)
217. J. Schmitt, K. Schakel, R. Folster-Holst, A. Bauer, R. Oertel, and M. Augustin Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial Br J Dermatol 162 2010 661 668 (Ib)
218. S.C. Weatherhead, S. Wahie, N.J. Reynolds, and S.J. Meggitt An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema Br J Dermatol 156 2007 346 351 (IIb)
219. C. Goujon, F. Berard, K. Dahel, I. Guillot, A. Hennino, and A. Nosbaum Methotrexate for the treatment of adult atopic dermatitis Eur J Dermatol 16 2006 155 158 (IIb)
220. A. Lyakhovitsky, A. Barzilai, R. Heyman, S. Baum, B. Amichai, and M. Solomon Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults J Eur Acad Dermatol Venereol 24 2010 43 49 (IIb)
221. D. Abeck, T. Schmidt, H. Fesq, K. Strom, M. Mempel, and K. Brockow Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis J Am Acad Dermatol 42 2000 254 257
222. J. Krutmann, W. Czech, T. Diepgen, R. Niedner, A. Kapp, and E. Schopf High-dose UVA1 therapy in the treatment of patients with atopic dermatitis J Am Acad Dermatol 26 1992 225 230 (Ib)
223. T.H. Clayton, S.M. Clark, D. Turner, and V. Goulden The treatment of severe atopic dermatitis in childhood with narrowband ultraviolet B phototherapy Clin Exp Dermatol 32 2007 28 33 (III)
224. D. Amrol Anti-immunoglobulin e in the treatment of refractory atopic dermatitis South Med J 103 2010 554 558 (III)
225. K.S. Suh, J.S. Kang, J.W. Baek, T.K. Kim, J.W. Lee, and Y.S. Jeon Efficacy of ultraviolet A1 phototherapy in recalcitrant skin diseases Ann Dermatol 22 2010 1 8 (III)
226. N.B. Meduri, T. Vandergriff, H. Rasmussen, and H. Jacobe Phototherapy in the management of atopic dermatitis: a systematic review Photodermatol Photoimmunol Photomed 23 2007 106 112 (III)
227. T. Gambichler, N. Othlinghaus, N.S. Tomi, T. Holland-Letz, S. Boms, and M. Skrygan Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study Br J Dermatol 160 2009 652 658 (Ib)
228. I.M. Majoie, J.M. Oldhoff, H. van Weelden, M. Laaper-Ertmann, M.T. Bousema, and V. Sigurdsson Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis J Am Acad Dermatol 60 2009 77 84 (Ib)
229. S. Tzaneva, H. Kittler, G. Holzer, D. Reljic, M. Weber, and H. Honigsmann 5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: a randomized crossover trial Br J Dermatol 162 2010 655 660 (Ib)
230. L. Cox, H. Nelson, R. Lockey, C. Calabria, T. Chacko, and I. Finegold Allergen immunotherapy: a practice parameter third update J Allergy Clin Immunol 127 suppl 2011 S1 S55 (B)
231. C. Bussmann, A. Bockenhoff, H. Henke, T. Werfel, and N. Novak Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol 118 2006 1292 1298 (IV)
232. M.T. Glover, and D.J. Atherton A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema Clin Exp Allergy 22 1992 440 446 (Ib)
233. T. Werfel, K. Breuer, F. Rueff, B. Przybilla, M. Worm, and M. Grewe Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study Allergy 61 2006 202 205 (Ib)
234. C. Bussmann, L. Maintz, J. Hart, J.P. Allam, S. Vrtala, and K.W. Chen Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study Clin Exp Allergy 37 2007 1277 1285 (III)
235. G.B. Pajno, L. Caminiti, D. Vita, G. Barberio, G. Salzano, and F. Lombardo Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study J Allergy Clin Immunol 120 2007 164 170 (Ib)
236. S. Takei, Y.K. Arora, and S.M. Walker Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens J Clin Invest 91 1993 602 607
237. S. Jolles A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis Clin Exp Dermatol 27 2002 3 7 (IV)
238. S.J. Jee, J.H. Kim, H.S. Baek, H.B. Lee, and J.W. Oh Long-term efficacy of intravenous immunoglobulin therapy for moderate to severe childhood atopic dermatitis Allergy Asthma Immunol Res 3 2011 89 95 (Ib)
239. B. Belloni, M. Ziai, A. Lim, B. Lemercier, M. Sbornik, and S. Weidinger Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels J Allergy Clin Immunol 120 2007 1223 1225 (III)
240. C. Caruso, F. Gaeta, R.L. Valluzzi, and A. Romano Omalizumab efficacy in a girl with atopic eczema Allergy 65 2010 278 279 (III)
241. S.B. Forman, and A.B. Garrett Success of omalizumab as monotherapy in adult atopic dermatitis: case report and discussion of the high-affinity immunoglobulin E receptor, FcepsilonRI Cutis 80 2007 38 40 (III)
242. R.A. Krathen, and S. Hsu Failure of omalizumab for treatment of severe adult atopic dermatitis J Am Acad Dermatol 53 2005 338 340 (III)
243. S.Y. Park, M.R. Choi, J.I. Na, S.W. Youn, K.C. Park, and C.H. Huh Recalcitrant atopic dermatitis treated with omalizumab Ann Dermatol 22 2010 349 352 (III)
244. P.G. Vigo, K.R. Girgis, B.L. Pfuetze, M.E. Critchlow, J. Fisher, and I. Hussain Efficacy of anti-IgE therapy in patients with atopic dermatitis J Am Acad Dermatol 55 2006 168 170 (III)
245. L.E. Sheinkopf, A.W. Rafi, L.T. Do, R.M. Katz, and W.B. Klaustermeyer Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study Allergy Asthma Proc 29 2008 530 537 (IIb)
246. P.M. Heil, D. Maurer, B. Klein, T. Hultsch, and G. Stingl Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study J Dtsch Dermatol Ges 8 2010 990 998 (Ib)
247. D. Simon, S. Hosli, G. Kostylina, N. Yawalkar, and H.U. Simon Anti-CD20 (rituximab) treatment improves atopic eczema J Allergy Clin Immunol 121 2008 122 128 (IIb)
248. P. Ponte, and M.J. Lopes Apparent safe use of single dose rituximab for recalcitrant atopic dermatitis in the first trimester of a twin pregnancy J Am Acad Dermatol 63 2010 355 356 (III)
249. A. Sediva, J. Kayserova, E. Vernerova, A. Polouckova, S. Capkova, and R. Spisek Anti-CD20 (rituximab) treatment for atopic eczema J Allergy Clin Immunol 121 2008 1515 1517 (III)